FdaApplication
ANDA 206682
Identifiers
- fda_app_no: ANDA206682
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI IPSUM SRL |
| application_type | ANDA |
| approval_date | 2019-12-10 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAFCILLIN SODIUM | NAFCILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INJECTION |
| NAFCILLIN SODIUM | NAFCILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE;INJECTION |
2 products